Age-related inflammatory cytokines and disease.

By Helle Brüünsgaard, B. K. Pedersen. Immunology and allergy clinics of North America, 2003

625 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology, Physiology

View Paper: https://www.semanticscholar.org/paper/d138e423c2ca6ba335c9e0c3e0312ed51d62726b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. B. K. Pedersen
2. M. Febbraio
3. J. Campisi
4. Haiming Cao
5. G. Steinberg
6. Bruce E. Kemp
7. B. Saltin
8. I. Goshen

In Immunology

1. J. Kirkland
2. T. Tchkonia
3. M. Febbraio
4. J. V. van Deursen
5. Yi Zhu
6. J. Campisi
7. B. K. Pedersen
8. I. Goshen

In Physiology

1. J. Kirkland
2. T. Tchkonia
3. B. K. Pedersen
4. J. Campisi
5. M. Febbraio
6. J. V. van Deursen
7. Yi Zhu
8. Jesús Gil

Citations in the corpus

• Visceral Adiposity Index (2010, background): “V isceral obesity (1) is associated with increased adipocytokine production, proinflammatory activity (2), deterioration of insulin sensitivity (3), increased risk of developing diabetes, “high-triglyceride/low–HDL cholesterol dyslipidemia,” hypertension, atherosclerosis, and higher mortality rate (”
• Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. (2013, positive): “Hallmarks of inflammation, including elevated IL-6, TNF-α , and immune cell chemokines, are associated with dementias (2), depression (3), atherosclerosis (4–8), cancers (9–11), diabetes (12– 14), and mortality (2, 15, 16).”
• Muscles and their myokines (2011, background): “Systemic low-level inflammation is defined as 2- to 4-fold elevations in circulating levels of pro-inflammatory and anti-inflammatory cytokines, naturally occurring cytokine antagonists, and acute-phase proteins, as well as minor increases in counts of neutrophils and natural killer cells (Bruunsgaa”
• Inflammatory mediators in the elderly. (2004, background): “Furthermore, TNF-a as well as IL-6 affect the coagulation system and metabolism of lipids, causing a procoagulant state and dyslipidaemia (reviewed in Bruunsgaard and Pedersen (2003)).”
• Muscle as an endocrine organ: focus on muscle-derived interleukin-6. (2008, background): “Systemic low-level inflammation is defined as two- to fourfold elevations in circulating levels of proinflammatory and anti-inflammatory cytokines, naturally occurring cytokine antagonists, and acute-phase proteins, as well as minor increases in counts of neutrophils and natural killer cells (45).”